The Fifth Affiliated Hospital of Guangzhou Medical University
The Fifth Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS) | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Site, Thoracic Neoplasms, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, intestinal disorder, liver cancer, liver disorder, lung cancer, lung disorder, lung neoplasm, neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-09-22 | NCT07834268 | |
| ASPIrin in Reducing Events in Dialysis ( ASPIRED ) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Phase 4 | 2026-09-14 | NCT04381143 | |
| Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath | Multiple Pulmonary Nodules, Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, pulmonary coin lesion, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2025-12-24 | NCT06518655 | |
| Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2025-11-17 | NCT06451861 |